Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat
- PMID: 8788863
- DOI: 10.1016/0166-4328(96)00138-6
Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat
Abstract
The effects of systemically administered phencyclidine (PCP; 2.5 mg/kg, s.c.) and D-amphetamine (1.5 mg/kg, s.c.) on the extracellular concentrations of neurotensin-like immunoreactivity (NT-LI) and dopamine (DA) in the ventral striatum (vSTR) and the medial prefrontal cortex (mPFC) were studied in freely moving rats using microdialysis. In separate animals, the effects of PCP and D-amphetamine on open field activity were also analyzed. PCP, but not D-amphetamine, caused a significant increase (156% over baseline) of NT-LI levels in the vSTR which was relatively short lasting, i.e., of less than 2 h duration. In contrast, both drugs significantly increased NT-LI concentrations in the mPFC by almost 100% during the same period. PCP and D-amphetamine also significantly increased extracellular levels of DA in the vSTR by 83 and 364%, respectively. However, the peak effect of PCP on DA appeared later than that of D-amphetamine, i.e., at 150 and 60 min, respectively, after drug administration. Also in the mPFC, both PCP and D-amphetamine significantly increased DA concentrations by 98 and 284%, respectively. Generally, effects on DA levels of both PCP and D-amphetamine were, in contrast to their effects on NT-LI levels, clearly more long-lasting, i.e., of 3-4 h duration. Behaviorally, D-amphetamine produced a more pronounced, general activation than PCP, with a faster onset of activation, i.e. within 30 vs 90 min after administration. However, both drugs produced long-lasting effects on the spatial organization of behavioral activity, which lasted for 3-4 h. In conclusion, the more pronounced behavioral stimulation by D-amphetamine (1.5 mg/kg, s.c.) vs PCP (2.5 mg/kg, s.c.) in the rat may largely be explained by its more potent DA-releasing effect in the brain. Initial behavioral suppression by PCP, e.g., of rearing, as well as its rather poor locomotor stimulant action in general, might relate to release of NT in the vSTR. The long-lasting, behavioral disorganization by both PCP and D-amphetamine may, however, be related to increased release of DA rather than NT in the mesolimbocortical areas.
Similar articles
-
The psychotomimetic drugs D-amphetamine and phencyclidine release calcitonin gene-related peptide in the limbic forebrain of the rat.J Neurosci Res. 1996 Nov 1;46(3):316-23. doi: 10.1002/(SICI)1097-4547(19961101)46:3<316::AID-JNR4>3.0.CO;2-N. J Neurosci Res. 1996. PMID: 8933370
-
The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.Brain Res. 2010 Jan 22;1311:28-36. doi: 10.1016/j.brainres.2009.11.048. Epub 2009 Nov 27. Brain Res. 2010. PMID: 19948149 Free PMC article.
-
d-Amphetamine-induced increase in neurotensin and neuropeptide Y outflow in the ventral striatum is mediated via stimulation of dopamine D1 and D2/3 receptors.J Neurosci Res. 2002 Jul 1;69(1):133-9. doi: 10.1002/jnr.10276. J Neurosci Res. 2002. PMID: 12111825
-
The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis.Behav Brain Res. 1996 Jan;74(1-2):45-55. doi: 10.1016/0166-4328(95)00162-x. Behav Brain Res. 1996. PMID: 8851914 Review.
-
The phencyclidine-glutamate model of schizophrenia.Clin Neuropharmacol. 1995 Jun;18(3):237-49. doi: 10.1097/00002826-199506000-00004. Clin Neuropharmacol. 1995. PMID: 8635182 Review.
Cited by
-
Effects of neurotensin gene knockout in mice on the behavioral effects of cocaine.Psychopharmacology (Berl). 2012 Jan;219(1):35-45. doi: 10.1007/s00213-011-2370-9. Epub 2011 Jul 1. Psychopharmacology (Berl). 2012. PMID: 21720755
-
TDO as a therapeutic target in brain diseases.Metab Brain Dis. 2016 Aug;31(4):737-47. doi: 10.1007/s11011-016-9824-z. Epub 2016 Apr 13. Metab Brain Dis. 2016. PMID: 27072164 Review.
-
Similarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: relevance to schizophrenia.Neurobiol Dis. 2010 Nov;40(2):467-77. doi: 10.1016/j.nbd.2010.07.011. Epub 2010 Jul 24. Neurobiol Dis. 2010. PMID: 20659557 Free PMC article.
-
Influence of CGS 21680, a selective adenosine A(2A) agonist, on the phencyclidine-induced sensorimotor gating deficit and motor behaviour in rats.Psychopharmacology (Berl). 2003 Jul;168(3):299-306. doi: 10.1007/s00213-003-1439-5. Epub 2003 Apr 9. Psychopharmacology (Berl). 2003. PMID: 12684736
-
Involvement of the Striatal Medium Spiny Neurons of the Direct Pathway in the Motor Stimulant Effects of Phencyclidine.Int J Neuropsychopharmacol. 2016 Jun 1;19(6):pyv134. doi: 10.1093/ijnp/pyv134. Epub 2015 Dec 9. Int J Neuropsychopharmacol. 2016. PMID: 26657176 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials